How do you pay?

How to pay the least

From

$15 for 30 tablets

Generic imatinib from Rx Outreach, by mail. Pick the strength on your label above for its own price.

  1. Make a free account on rxoutreach.org. Ask your prescriber to send the prescription there, or Rx Outreach can transfer it.Open Rx Outreach 
  2. Order generic imatinib. It comes by mail.

Need it today? From $21.98 for 30 tablets with the free Team Cuban Card, at pharmacies that take it. Get the free card and show it there.

See the price and get the card 

A regular generic has the same active ingredient as Gleevec, and the FDA requires it to work the same way.

Compare every option

Question
Brand nameGleevec
Authorized genericimatinib
Regular genericimatinib
What you’d pay
Cash priceAsk the pharmacyUsually the highest price
Not soldThere isn’t one
From$15for 30 tablets at Rx Outreach
Same as Gleevec?
The original
–
Same active ingredientFillers and dyes can differ

Brand nameThe maker’s card

Novartis Oncology Universal Co-pay Program

Savings card from Novartis

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $10 a month

The card takes up to $30,000 a year off your co-pay.

Sign up on copay.novartisoncology.com 

Or call 1-877-577-7756.

In the maker’s words

“Patients are responsible for the first $10 co-pay for a 30-day supply and Novartis will pay up to $10,630 per 30-day supply up to $30,000 per calendar year.”

From the maker’s offer on copay.novartisoncology.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Gleevec itself, from the same company, sold without the brand name, and usually for less. A regular generic is sold, with the same active ingredient: ask the pharmacy for its price.

See the regular generic →

Regular genericWhere to buy it

Pharmacies’ own cash prices for generic imatinib, lowest first.

Pick up in storeDelivered

From each pharmacy’s own site, read November 2, 2026. Confirm the price before you fill.

About these prices

Prices change, can differ by store and state, and may depend on the strength and how many you take. With insurance, ask what your plan charges; it can be less.

Regular genericMakers and their savings cards

10 companies sell a generic of Gleevec that the FDA rates a substitute. A pharmacy fills whichever one it stocks. 2 of them have their own savings cards or programs, listed first. Each works only with that maker’s version. To get a certain maker, ask for it by name; most pharmacies can order it in a day or two.

  • Teva PharmaceuticalsAll 2 strengths

    Has lactose · Has a dye: FD&C Yellow No. 6

    Teva Imatinib Mesylate Tablets savings card

    With commercial insurance as little as $0

    Print the card (PDF)

    Or call 1-844-248-7949. See the offer on tevausa.com

    In the maker’s words

    “Commercially insured patients may pay as little as $0 out of pocket for Teva's Imatinib Mesylate Tablets.”

    Product page on tevausa.com

    How it looks, what’s in it, NDCs

    100 mg Orange to brown, round, 9 mm, marked “TE / VA / 7629”

    PackageNDC
    Bottle of 900093-7629-98

    400 mg Orange to brown, oval, 19 mm, marked “TE / VA / 7630”

    PackageNDC
    Bottle of 300093-7630-56

    Inactive ingredients: silicon dioxide, croscarmellose sodium, crospovidone (12 mpa.s at 5%), FD&C Yellow No. 6, hydroxypropyl cellulose, hypromellose 2910 (6 mpa.s), ferric oxide yellow, lactose monohydrate, magnesium stearate, microcrystalline cellulose, sodium stearyl fumarate, talc, titanium dioxide

  • CivicaScriptAll 2 strengths

    Made by Hetero Labs

    MaxRP (maximum recommended price to the consumer)

    “CivicaScript’s MaxRP® policy is our maximum recommended price to the consumer.” (anyone)

    See the program

    How it looks, what’s in it, NDCs

    100 mg White to off white, round, 9 mm, marked “H / 7”

    PackageNDC
    Bottle of 9082249-020-90

    400 mg White to off white, oval, 19 mm, marked “H / 4”

    PackageNDC
    Bottle of 3082249-021-30

    Inactive ingredients: silicon dioxide, crospovidone (120 .mu.m), hypromellose 2910 (5 mpa.s), magnesium stearate, microcrystalline cellulose 102, polyethylene glycol 8000, talc, titanium dioxide, hypromellose 2910 (6 mpa.s)

    FDA label

  • ApotexAll 2 strengths
    How it looks, what’s in it, NDCs

    100 mg Brownish Orange, round, 9 mm, marked “IMA / 100 / APO”

    PackageNDC
    Bottle of 3060505-2900-3
    Bottle of 9060505-2900-9
    Carton of 10060505-2900-0
    Bottle of 10060505-2900-1
    Bottle of 100060505-2900-8

    400 mg Brownish Orange, capsule, 17 mm, marked “IMA / 400 / APO”

    PackageNDC
    Bottle of 3060505-2901-3
    Bottle of 9060505-2901-9
    Carton of 10060505-2901-0
    Bottle of 10060505-2901-1
    Bottle of 50060505-2901-5

    Inactive ingredients: silicon dioxide, crospovidone (120 .mu.m), magnesium stearate, hypromellose 2910 (5 mpa.s), hydroxypropyl cellulose (90000 wamw), ferric oxide red, ferric oxide yellow, polyethylene glycol 8000

    FDA label

  • Aurobindo PharmaAll 2 strengths

    Made by Eugia Pharma Specialities

    Product page on aurobindousa.com

    How it looks, what’s in it, NDCs

    100 mg Very dark Yellow to Brownish Orange, round, 9 mm, marked “100”

    PackageNDC
    Bottle of 9059651-240-90

    400 mg Very dark Yellow to Brownish Orange, oval, 20 mm, marked “400”

    PackageNDC
    Carton of 3059651-241-03
    Bottle of 3059651-241-30

    Inactive ingredients: silicon dioxide, crospovidone (120 .mu.m), hypromellose 2910 (3 mpa.s), ferric oxide red, ferric oxide yellow, magnesium stearate, microcrystalline cellulose 102, microcrystalline cellulose 200, polyethylene glycol 3350, talc

    FDA label

  • BluePoint LaboratoriesAll 2 strengths

    Made by Eugia Pharma Specialities

    How it looks, what’s in it, NDCs

    100 mg Very dark Yellow to Brownish Orange, round, 9 mm, marked “100”

    PackageNDC
    Bottle of 9068001-622-05

    400 mg Very dark Yellow to Brownish Orange, oval, 20 mm, marked “400”

    PackageNDC
    Bottle of 3068001-623-04

    Inactive ingredients: silicon dioxide, crospovidone (120 .mu.m), hypromellose 2910 (3 mpa.s), ferric oxide red, ferric oxide yellow, magnesium stearate, microcrystalline cellulose 102, microcrystalline cellulose 200, polyethylene glycol 3350, talc

  • Camber PharmaceuticalsAll 2 strengths

    Made by Hetero Labs

    Product page on camberpharma.com

    How it looks, what’s in it, NDCs

    100 mg White to off white, round, 9 mm, marked “H / 7”

    PackageNDC
    Bottle of 9031722-296-90

    400 mg White to off white, oval, 19 mm, marked “H / 4”

    PackageNDC
    Bottle of 3031722-297-30

    Inactive ingredients: silicon dioxide, crospovidone (120 .mu.m), hypromellose 2910 (5 mpa.s), magnesium stearate, microcrystalline cellulose 102, polyethylene glycol 8000, talc, titanium dioxide, hypromellose 2910 (6 mpa.s)

    FDA label

  • Chartwell RXAll 2 strengths
    How it looks, what’s in it, NDCs

    100 mg Light Orange, round, 7 mm, marked “CE / 138”

    PackageNDC
    Bottle of 9062135-658-90

    400 mg Light Orange, capsule, 16 mm, marked “CE / 139”

    PackageNDC
    Bottle of 3062135-659-30

    Inactive ingredients: magnesium stearate, povidone, ferric oxide yellow, hypromellose, polyethylene glycol, titanium dioxide

    FDA label

  • Mylan InstitutionalAll 2 strengths
    How it looks, what’s in it, NDCs

    100 mg Brown-orange, round, 9 mm, marked “M / I / 100”

    PackageNDC
    Carton of 3042292-043-03

    400 mg Brown-orange, oval, 19 mm, marked “MYLAN / I / 400”

    PackageNDC
    Carton of 3042292-044-03

    Inactive ingredients: silicon dioxide, crospovidone, hypromellose 2910 (3 mpa.s), magnesium stearate, microcrystalline cellulose 200, polyethylene glycol 3350, polyvinyl alcohol, ferric oxide red, talc, titanium dioxide, ferric oxide yellow, microcrystalline cellulose

    FDA label

  • Mylan PharmaceuticalsAll 2 strengths

    Product page on viatris.com

    How it looks, what’s in it, NDCs

    100 mg Brown-orange, round, 9 mm, marked “M / I / 100”

    PackageNDC
    Bottle of 900378-2245-77

    400 mg Brown-orange, oval, 19 mm, marked “MYLAN / I / 400”

    PackageNDC
    Bottle of 300378-2246-93

    Inactive ingredients: silicon dioxide, crospovidone, hypromellose 2910 (3 mpa.s), magnesium stearate, microcrystalline cellulose 200, polyethylene glycol 3350, polyvinyl alcohol, ferric oxide red, talc, titanium dioxide, ferric oxide yellow, microcrystalline cellulose

  • Upsher-Smith LaboratoriesAll 2 strengths

    Made by Qilu Pharm Hainan · Being phased out; sold until January 2027

    How it looks, what’s in it, NDCs

    100 mg Brown, round, 9 mm, marked “51”

    PackageNDC
    Bottle of 900832-0532-09

    400 mg Brown, oval, 19 mm, marked “52”

    PackageNDC
    Bottle of 300832-0533-03

    Inactive ingredients: silicon dioxide, crospovidone, ferric oxide red, magnesium stearate, cellulose, microcrystalline, polyethylene glycol 8000, talc, hypromellose 2910 (5 mpa.s), hypromellose 2910 (6 mpa.s), ferric oxide yellow, water

    FDA label

Who sells it: FDA and Medicaid records, updated weekly. Each maker’s page, card and program is from its own site, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

What to say at the pharmacy

“Before you fill my Gleevec, can you tell me what I’d pay for the brand and for a generic?”

Paying cash? Ask for each one’s cash price. With insurance, ask what your plan charges for each.

What it’s used for

What the FDA label says

Gleevec is a kinase inhibitor indicated for the treatment of:

  • Newly diagnosed adult and pediatric patients with Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase.
  • Patients with Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in blast crisis (BC), accelerated phase (AP), or in chronic phase (CP) after failure of interferon-alpha therapy.
  • Adult patients with relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL).
  • Pediatric patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL) in combination with chemotherapy.
  • Adult patients with myelodysplastic/myeloproliferative diseases (MDS/MPD) associated with platelet-derived growth factor receptor (PDGFR) gene re-arrangements.
  • Adult patients with aggressive systemic mastocytosis (ASM) without the D816V c-Kit mutation or with c-Kit mutational status unknown.
  • Adult patients with hypereosinophilic syndrome (HES) and/or chronic eosinophilic leukemia (CEL) who have the FIP1L1-PDGFRα fusion kinase (mutational analysis or fluorescence in situ hybridization [FISH] demonstration of CHIC2 allele deletion) and for patients with HES and/or CEL who are FIP1L1-PDGFRα fusion kinase negative or unknown.
  • Adult patients with unresectable, recurrent and/or metastatic dermatofibrosarcoma protuberans (DFSP).
  • Patients with Kit (CD117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumors (GIST).
  • Adjuvant treatment of adult patients following resection of Kit (CD117) positive GIST.

Source: the FDA label for Gleevec (Novartis Pharmaceuticals Corporation), July 13, 2026. Full label on DailyMed 

Good to know